SHANGHAI – An unlikely union has been forged between San Francisco-based Unity Biotechnology Inc., a biopharma focused on developing anti-aging drugs to improve healthy life span, and Ascentage Pharma Group, of Taizhou, Zhejiang, a clinical-stage firm focused on apoptosis-targeted oncology drug discovery and development.